Elisabetta Zappone
Siena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Low rate of infectious mortality omitting fluoroquinolone prophylaxis in high-risk hematological patients, a single centre experience.
Journal: Frontiers in microbiology
Published: May 20, 2025
Allogeneic Hematopoietic Stem Cell Transplantation Despite Severe Fusarium solani Infection in a Lung Transplanted Patient-A Case Report.
Journal: Microorganisms
Published: December 23, 2024
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
Journal: Hematological oncology
Published: April 04, 2021
First reported case of secondary mixed phenotype acute leukemia after multiple myeloma.
Journal: American journal of blood research
Published: June 29, 2020
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients.
Journal: Frontiers in oncology
Published: June 06, 2020
Venetoclax in association with decitabine as effective bridge to transplant in a case of relapsed early T-cell lymphoblastic leukemia.
Journal: Clinical case reports
Published: February 12, 2020
FLT3 Inhibitors in the Management of Acute Myeloid Leukemia.
Journal: Anti-cancer agents in medicinal chemistry
Published: September 26, 2015
Haploidentical HSCT: a 15-year experience at San Raffaele.
Journal: Bone marrow transplantation
Published: June 04, 2015
Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells.
Journal: Frontiers in immunology
Published: October 28, 2013
Plerixafor and autologous stem cell transplantation: impressive result in a chemoresistant testicular cancer patient treated with high-dose chemotherapy.
Journal: Anti-cancer drugs
Published: May 24, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026